Skip to main content
EJNMMI Physics
Fig. 3 | EJNMMI Physics

Fig. 3

From: Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parameters

Fig. 3

Tumour cell heterogeneity within the metastatic CRC liver malignancy. a The deformably registered pre- and post-treatment [18F] FDG PET images with two lesions on the right and left lobes are shown with the white contours. b, c The estimated voxel SF and TCP for both lesions. The survival fraction and TCP were calculated based on the 90Y absorbed dose and SUV volume histograms. The radiobiological parameters were derived from the GLQ fit for each individual lesion

Back to article page